Increasing thirty-day readmissions of Crohn’s disease and ulcerative colitis in the United States: A national dilemma
Abstract BACKGROUND: The prevalence of Crohn’s disease (CD) and ulcerative colitis (UC) is on the rise worldwide. This rising prevalence is concerning as patients with CD and UC may frequently relapse leading to recurrent hospitalizations and increased healthcare utilization. AIM: To identify trends and adverse outcomes for 30 d readmissions for CD and UC. METHODS: This was a retrospective, interrupted trends study involving all adult (≥ 18 years) 30 d readmissions of CD and UC from the National Readmission Database
This article is available to registered members
Create a free account to access our full library of peer-reviewed research on medical cannabis.
Join — it's freeAlready a member? Log in
